The global Parkinson's disease therapeutics market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of Parkinson's disease and rising geriatric population.
Medications therapeutics accounted for the largest share in the global Parkinson's disease therapeutics market in 2018, followed by medical devices therapeutics and other therapies. Medications are used for treating symptoms of Parkinson's disease such as tremors, stiffness, slowness of movement and rigidity. Medical devices are used for treating symptoms such as tremors and rigidity. Other therapies include deep brain stimulation (DBS) therapy which is a surgical procedure that involves implanting electrodes into specific areas of the brain to control abnormal nerve impulses that cause tremor or rigidity in patients with Parkinson’s disease; transcranial magnetic stimulation (TMS) therapy which involves applying magnetic pulses on specific parts of the brain through a coil placed on top of head; and exercise therapy which includes physical exercises like yoga or tai chi to improve mobility in patients with Parkinson’s disease.
North America accounted for the largest share in global markets owing to high prevalence rates among people aged above 65 years old coupled with high healthcare expenditure per capita among developed countries including US, Canada, UK etc, whereas Asia Pacific was expected to witness fastest growth due to increasing awareness about PD coupled with low healthcare expenditure per capita among developing countries including India, China etc, during forecast period from 2021-2030.
-Parkinson's Disease Therapeutics market growth is driven by the increasing prevalence of Parkinson's Disease. -The number of people with Parkinson's Disease is expected to increase from 1 million in 2010 to 2 million in 2030. -Parkinson's Disease Therapeutics market growth is also driven by the increasing incidence rate of Parkinson’s disease, which has been estimated at 3% per year. -Increasing research and development activities for new drugs are also driving the growth of this market.
Industry Growth Insights published a new data on “Parkinson's Disease Therapeutics Market”. The research report is titled “Parkinson's Disease Therapeutics Market research by Types (Medications Therapeutics, Medical Devices Therapeutics), By Applications (Under 40 Years Old, 40-65 Years Old, Above 65 Years Old), By Players/Companies GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Merck, Akorn, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Parkinson's Disease Therapeutics Market Research Report
By Type
Medications Therapeutics, Medical Devices Therapeutics
By Application
Under 40 Years Old, 40-65 Years Old, Above 65 Years Old
By Companies
GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Merck, Akorn, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Parkinson's Disease Therapeutics Market Report Segments:
The global Parkinson's Disease Therapeutics market is segmented on the basis of:
Types
Medications Therapeutics, Medical Devices Therapeutics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Under 40 Years Old, 40-65 Years Old, Above 65 Years Old
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Merck
- Akorn
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Bausch Health
Highlights of The Parkinson's Disease Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medications Therapeutics
- Medical Devices Therapeutics
- By Application:
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Parkinson's Disease Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Parkinson's Disease Therapeutics is a research and development company focused on developing treatments for Parkinson's disease. The company was founded in 2006 by Dr. Michael S. Jankowski and Dr. John A. Freeman, both of whom are experts in the field of Parkinson's disease research and treatment
Some of the major players in the parkinson's disease therapeutics market are GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Merck, Akorn, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health.
The parkinson's disease therapeutics market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Parkinson's Disease Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Parkinson's Disease Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Parkinson's Disease Therapeutics Market - Supply Chain
4.5. Global Parkinson's Disease Therapeutics Market Forecast
4.5.1. Parkinson's Disease Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Parkinson's Disease Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Parkinson's Disease Therapeutics Market Absolute $ Opportunity
5. Global Parkinson's Disease Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Parkinson's Disease Therapeutics Market Size and Volume Forecast by Type
5.3.1. Medications Therapeutics
5.3.2. Medical Devices Therapeutics
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Parkinson's Disease Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Parkinson's Disease Therapeutics Market Size and Volume Forecast by Application
6.3.1. Under 40 Years Old
6.3.2. 40-65 Years Old
6.3.3. Above 65 Years Old
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Parkinson's Disease Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Parkinson's Disease Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Parkinson's Disease Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Parkinson's Disease Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Parkinson's Disease Therapeutics Demand Share Forecast, 2019-2026
9. North America Parkinson's Disease Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Parkinson's Disease Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Parkinson's Disease Therapeutics Market Size and Volume Forecast by Application
9.4.1. Under 40 Years Old
9.4.2. 40-65 Years Old
9.4.3. Above 65 Years Old
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Parkinson's Disease Therapeutics Market Size and Volume Forecast by Type
9.7.1. Medications Therapeutics
9.7.2. Medical Devices Therapeutics
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Parkinson's Disease Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Parkinson's Disease Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Parkinson's Disease Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Parkinson's Disease Therapeutics Market Size and Volume Forecast by Application
10.4.1. Under 40 Years Old
10.4.2. 40-65 Years Old
10.4.3. Above 65 Years Old
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Parkinson's Disease Therapeutics Market Size and Volume Forecast by Type
10.7.1. Medications Therapeutics
10.7.2. Medical Devices Therapeutics
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Parkinson's Disease Therapeutics Demand Share Forecast, 2019-2026
11. Europe Parkinson's Disease Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Parkinson's Disease Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Parkinson's Disease Therapeutics Market Size and Volume Forecast by Application
11.4.1. Under 40 Years Old
11.4.2. 40-65 Years Old
11.4.3. Above 65 Years Old
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Parkinson's Disease Therapeutics Market Size and Volume Forecast by Type
11.7.1. Medications Therapeutics
11.7.2. Medical evices Therapeutics
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Parkinson's Disease Therapeutics Demand Share, 2019-2026
12. Asia Pacific Parkinson's Disease Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Parkinson's Disease Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Parkinson's Disease Therapeutics Market Size and Volume Forecast by Application
12.4.1. Under 40 Years Old
12.4.2. 40-65 Years Old
12.4.3. Above 65 Years Old
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Parkinson's Disease Therapeutics Market Size and Volume Forecast by Type
12.7.1. Medications Therapeutics
12.7.2. Medical Devices Therapeutics
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Parkinson's Disease Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Parkinson's Disease Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Parkinson's Disease Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Parkinson's Disease Therapeutics Market Size and Volume Forecast by Application
13.4.1. Under 40 Years Old
13.4.2. 40-65 Years Old
13.4.3. Above 65 Years Old
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Parkinson's Disease Therapeutics Market Size and Volume Forecast by Type
13.7.1. Medications Therapeutics
13.7.2. Medical Devices Therapeutics
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Parkinson's Disease Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Parkinson's Disease Therapeutics Market: Market Share Analysis
14.2. Parkinson's Disease Therapeutics Distributors and Customers
14.3. Parkinson's Disease Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boehringer Ingelheim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teva Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbvie
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Akorn
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Kyowa Hakko Kirin Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Astellas Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Desitin Arzneimittel
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Endo Pharmaceuticals
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. F.Hoffmann-La Roche
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. H.Lundbeck
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Valeant
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Apokyn
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Orion
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Stada Arzneimittel
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. US WorldMeds
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Bausch Health
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
